Insider · CIK 0001855973

Desai Veeral

Reports to the SEC for 1 company · LONG BEACH, CA

sec.gov

Transactions

Companies

Filings

CIK

0001855973

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-15	AGLagilon health, inc.A Award	Chief Strategy & Dev. Officer	AAward	+196K sh	—	—	502,830
2024-04-15	AGLagilon health, inc. · Options (Right to buy)A Award	Chief Strategy & Dev. Officer	AAward	+323K sh	—	—	322,879
2024-04-14	AGLagilon health, inc.F Tax Payment	Chief Strategy & Dev. Officer	FTax Payment	−4,817 sh	$4.95	−$23.8K	498,013
2024-03-14	AGLagilon health, inc.P Purchase	Chief Strategy & Dev. Officer	PPurchase	+12K sh	—	—	311,541
2024-03-14	AGLagilon health, inc.F Tax Payment	Chief Strategy & Dev. Officer	FTax Payment	−4,900 sh	$5.23	−$25.6K	306,641
2023-05-09	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+4,500 sh	$3.00	+$13.5K	304,085
2023-05-09	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−4,500 sh	$26.15	−$118K	299,585
2023-05-09	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−4,500 sh	—	—	1,510,000
2023-04-20	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+500 sh	$3.00	+$1,500	300,085
2023-04-20	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−500 sh	$26.15	−$13.1K	299,585
2023-04-20	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−500 sh	—	—	1,514,500
2023-04-19	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+5,000 sh	$3.00	+$15K	304,585
2023-04-19	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−4,545 sh	$26.82	−$122K	300,040
2023-04-19	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−455 sh	$27.84	−$12.7K	299,585
2023-04-19	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−5,000 sh	—	—	1,515,000
2023-04-14	AGLagilon health, inc.A Award	Chief Strategy & Dev. Officer	AAward	+26.4K sh	—	—	303,082
2023-04-14	AGLagilon health, inc.F Tax Payment	Chief Strategy & Dev. Officer	FTax Payment	−3,497 sh	$28.46	−$99.5K	299,585
2023-04-14	AGLagilon health, inc. · Options (Rights to Buy)A Award	Chief Strategy & Dev. Officer	AAward	+45.6K sh	—	—	45,566
2023-03-24	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+97.3K sh	$3.00	+$292K	374,019
2023-03-24	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−97.3K sh	$28.70	−$2.79M	276,729
2023-03-24	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−97.3K sh	—	—	1,520,000
2023-03-23	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+22.7K sh	$3.00	+$68.1K	299,439
2023-03-23	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−22.7K sh	$28.71	−$652K	276,729
2023-03-23	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−22.7K sh	—	—	1,617,290
2023-03-16	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+60K sh	$3.00	+$180K	336,729
2023-03-16	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−60K sh	$26.09	−$1.57M	276,729
2023-03-16	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−60K sh	—	—	1,640,000
2022-07-21	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+79.8K sh	$1.00	+$79.8K	357,979
2022-07-21	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−79.8K sh	$27.50	−$2.19M	278,211
2022-07-21	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−79.8K sh	—	—	57,441
2022-07-07	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+319K sh	$1.00	+$319K	597,282
2022-07-07	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−319K sh	$25.00	−$7.98M	278,211
2022-07-07	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−319K sh	—	—	137,209
2022-06-24	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+106K sh	$1.00	+$106K	384,568
2022-06-24	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−106K sh	$22.50	−$2.39M	278,211
2022-06-24	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−106K sh	—	—	456,280
2022-04-22	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+26.8K sh	$1.00	+$26.8K	305,000
2022-04-22	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−26.8K sh	$20.00	−$536K	278,211
2022-04-22	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−26.8K sh	—	—	562,637
2022-04-21	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+79.6K sh	$1.00	+$79.6K	357,779
2022-04-21	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−69.8K sh	$20.43	−$1.43M	287,955
2022-04-21	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−9,744 sh	$21.35	−$208K	278,211
2022-04-21	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−79.6K sh	—	—	589,426
2022-04-20	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+106K sh	$1.00	+$106K	384,568
2022-04-20	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−106K sh	$22.34	−$2.38M	278,211
2022-04-20	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−106K sh	—	—	668,994
2022-04-19	AGLagilon health, inc.M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	+106K sh	$1.00	+$106K	384,568
2022-04-19	AGLagilon health, inc.S Sale	Chief Strategy & Dev. Officer	SSale	−106K sh	$22.74	−$2.42M	278,211
2022-04-19	AGLagilon health, inc. · Options (Rights to Buy)M Exercise/Conversion	Chief Strategy & Dev. Officer	MExercise/Conversion	−106K sh	—	—	775,351
2022-04-14	AGLagilon health, inc.A Award	Chief Strategy & Dev. Officer	AAward	+16.3K sh	—	—	278,211

Recent filings

Accepted (ET)
Apr 174
Desai Veeral0001628280-24-016653
SEC(opens sec.gov)
Mar 184
Desai Veeral0001628280-24-011773
SEC(opens sec.gov)
May 114
Desai Veeral0001209191-23-028800
SEC(opens sec.gov)
Apr 214
Desai Veeral0001209191-23-025112
SEC(opens sec.gov)
Apr 184
Desai Veeral0001209191-23-024666
SEC(opens sec.gov)
Mar 274
Desai Veeral0001209191-23-021209
SEC(opens sec.gov)

Companies

agilon health, inc.Chief Strategy & Dev. OfficerAGL

Address

C/O AGILON HEALTH, INC. 1 WORLD TRADE CENTER, SUITE 2000

LONG BEACH, CA, 90831